Genetic pathways to glioblastoma: a population-based study.

Area of Science:

• Neuro-oncology
• Cancer Genetics
• Epidemiology

Background:

• Glioblastoma is an aggressive primary brain tumor with poor prognosis.
• Understanding genetic alterations is crucial for glioblastoma research and treatment strategies.

Purpose of the Study:

• To determine the frequency of major genetic alterations in glioblastomas.
• To investigate the effect of these genetic alterations on patient survival.
• To compare genetic profiles and mutation mechanisms between primary and secondary glioblastomas.

Main Methods:

• Population-based study of 715 glioblastomas diagnosed in Zurich, Switzerland (1980-1994).
• Analysis of incidence rates, survival data, and major genetic alterations including Loss of Heterozygosity (LOH) 10q, EGFR amplification, TP53 mutations, p16(INK4a) deletion, and PTEN mutations.
• Comparison of genetic features between primary (de novo) and secondary glioblastomas.

Main Results:

• Incidence rates were 3.32/100,000 in males and 2.24/100,000 in females.
• Observed survival rates were 42.4% at 6 months, 17.7% at 1 year, and 3.3% at 2 years.
• Loss of heterozygosity 10q was the most frequent alteration (69%) and associated with shorter survival.
• TP53 mutations were more common in secondary glioblastomas (65%) with specific hotspot mutations.
• G:C-->A:T mutations at CpG sites were more frequent in secondary glioblastomas (56% vs. 30%).

Conclusions:

• Loss of heterozygosity 10q is a frequent genetic alteration in glioblastoma and a negative prognostic marker.
• Primary and secondary glioblastomas exhibit distinct genetic profiles and TP53 mutation patterns, suggesting different etiological mechanisms.
• Younger age is associated with significantly longer survival in glioblastoma patients.